Colonoscope CF-Q145I

Hospital Endoscopy Departments

Hospital endoscopy departments require colonoscopy equipment that delivers reliable HD imaging with optical enhancement across high-volume diagnostic, surveillance, and therapeutic lists. The CF-Q145I's NBI capability supports polyp characterisation and real-time lesion assessment without dye spray, and its variable stiffness insertion tube supports efficient caecal intubation across anatomically varied patient populations. EVIS EXERA II platform integration and DICOM connectivity support structured reporting and endoscopy unit accreditation compliance.

Colorectal Cancer Screening Programmes

Bowel cancer screening colonoscopy requires consistent polyp detection and characterisation performance across diverse endoscopists and patient presentations. The CF-Q145I's NBI optical enhancement supports the visualisation and real-time characterisation of diminutive, flat, and sessile lesions that may be less apparent under standard white light. NBI-assisted characterisation supports endoscopists in achieving the adenoma detection rate benchmarks required by national bowel cancer screening quality assurance frameworks.

IBD and Dysplasia Surveillance

IBD surveillance colonoscopy requires detailed mucosal vascular and pit pattern assessment to detect dysplasia in chronically inflamed colorectal tissue. The CF-Q145I's NBI optical enhancement supports targeted mucosal evaluation to guide biopsy decisions during surveillance programmes. Variable stiffness assists navigation of post-surgical and strictured colons encountered in long-standing IBD patient populations during surveillance examinations.

Diagnostic and Therapeutic Colonoscopy

The CF-Q145I's NBI capability supports real-time lesion assessment during diagnostic colonoscopy, guiding targeted biopsy decisions and same-session polypectomy planning. Its working channel accommodates standard endoscopic accessories for biopsy, haemostasis, and polypectomy across the full range of colorectal therapeutic endoscopic interventions performed in routine clinical practice.

For Hospitals and Endoscopy Departments

The CF-Q145I integrates with Olympus EVIS EXERA II systems, supporting DICOM, EMR, and endoscopy reporting connectivity that meets the digital workflow requirements of accredited endoscopy departments. NBI optical enhancement supports adenoma detection rate quality indicators. CE certification and full compliance documentation satisfy hospital procurement and government tender requirements. Medigear.uk provides institutional buyers with full procurement documentation and after-sales service coordination.

For Specialist Gastroenterology Units and Screening Centres

The CF-Q145I provides specialist gastroenterology units and screening programmes with NBI-enhanced HD colonoscopy performance in a robust, clinically proven instrument compatible with existing Olympus EVIS EXERA II infrastructure. Variable stiffness supports efficient examination across anatomically complex patients, and NBI enhances characterisation performance across screening and surveillance indications including IBD and bowel cancer programmes.

For Medical Equipment Distributors

The CF-Q145I addresses consistent procurement demand from hospital endoscopy departments, specialist gastroenterology units, and colorectal cancer screening services for a reliable, CE-certified HD colonoscopy instrument with NBI optical enhancement. Medigear.uk supports authorised distributors with full documentation, technical training resources, and service infrastructure. Olympus's strong global reputation in endoscopy positions the CF-Q145I as a dependable distribution product with broad and consistent market demand.

Narrow Band Imaging Optical Enhancement

The CF-Q145I features Olympus NBI technology, which uses narrow-bandwidth blue and green light to enhance mucosal vascular architecture and surface microstructure during colonoscopy without chemical dye. NBI supports real-time polyp characterisation, lesion margin assessment, and differentiation of neoplastic tissue throughout the procedure.

High-Definition EVIS EXERA II Platform Imaging

The CF-Q145I delivers high-definition colonoscopy imaging on the Olympus EVIS EXERA II CV-180 processor, providing sharp mucosal detail and accurate colour reproduction in both white light and NBI modes, supporting clear visualisation across the full range of colonoscopy indications.

Variable Stiffness Insertion Tube

An adjustable stiffness insertion tube allows the endoscopist to modify shaft rigidity during colonoscopy insertion, facilitating navigation through tortuous and anatomically challenging colons, improving caecal intubation rates, and reducing patient discomfort across varied anatomy.

Water Jet Irrigation Channel

A dedicated water jet channel supports mucosal washing during insertion and withdrawal, enabling clearer inspection of the colorectal surface and improved visualisation across varied bowel preparation quality throughout the colonoscopy procedure.

DICOM and EMR Connectivity

Integration with the Olympus EVIS EXERA II processor platform supports DICOM, EMR, and endoscopy reporting platform connectivity, enabling structured digital procedure documentation and direct data transfer into hospital endoscopy department management and quality assurance systems.

CE Certified for Clinical Colonoscopy Use

The CF-Q145I carries CE marking in compliance with applicable medical device directives, satisfying procurement compliance for hospitals, specialist endoscopy units, and regulated gastroenterology settings. Full documentation is available from Medigear.uk.

The Olympus CF-Q145I colonoscope delivers Narrow Band Imaging optical enhancement, high-definition EVIS EXERA II platform imaging, and variable stiffness insertion in a proven clinical instrument designed for the full diagnostic and therapeutic demands of hospital endoscopy departments, colorectal cancer screening programmes, and specialist gastroenterology units. Hospitals benefit from NBI-enhanced polyp characterisation that supports adenoma detection rate compliance and efficient therapeutic colonoscopy. Screening services value the CF-Q145I's consistent NBI performance and variable stiffness capability across anatomically varied patient populations. Distributors recognise it as a dependable Olympus EVIS EXERA II product with consistent procurement demand across hospital, screening, and specialist colonoscopy markets. Contact Medigear.uk for product specifications, procurement assistance, or expert consultation.